▲ Peaking
Health
Drugmakers uninterested in Trump’s order to split up MMR vaccine
Pharmaceutical companies are resisting a directive from President Trump to decouple the combined MMR vaccine into separate shots.
Merck
11 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✗
As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill
The FDA approves the first oral PCSK9 pill, Lipfendra, as Merck charts a long-term path.
◼ Archived
Health
🔮 fades ✓
Lipfendra vs statins: How these cholesterol-lowering drugs compare
Recent coverage examines how Lipfendra compares to traditional statins for lowering cholesterol.
◼ Archived
Business
🔮 fades ✗
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
Merck & Co. reports mixed Q2 2026 results, lifting sales forecasts on drug strength while cutting profit outlook due to acquisition costs.
◼ Archived
Health
🔮 fades
First person gets new experimental vaccine for Ebola
The world's first human clinical trial for a Bundibugyo ebolavirus vaccine has commenced following the first volunteer's vaccination.
◼ Archived
Business
🔮 fades
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is establishing global access and licensing frameworks for the world's first monthly oral HIV prevention pill ahead of its official approval.
◼ Archived
Business
🔮 fades
Merck gets US FDA nod for first-in-its-class oral cholesterol drug
Merck has achieved a regulatory milestone with the FDA approval of Lipfendra, the first-of-its-kind oral treatment for reducing cholesterol.
◼ Archived
Business
🔮 fades
Game-changing cholesterol pill wins FDA approval after cutting LDL nearly 60%
The FDA has approved Merck's Lipfendra, the first oral PCSK9 drug capable of lowering LDL cholesterol by nearly 60%.
◼ Archived
Business
🔮 holds
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved a first-of-its-kind daily oral pill from Merck designed to slash cholesterol levels.
◼ Archived
Business
🔮 fades
EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into major pharmaceutical companies regarding the use of clinical trial sites in China.
◼ Archived
Business
🔮 holds
Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
Merck KGaA, Darmstadt, Germany, has entered into an agreement to acquire Bio-Techne in an all-cash deal valued at $11.3 billion.